Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 3, 2009, Pages 367-372

  Gavidia, Cesar M ^a   Gonzalez, Armando E ^a   Lopera, Luis ^a   Jayashi, Cesar ^a   Angelats, Roxana ^a   Barron, Eduardo A ^a   Ninaquispe, Berenice ^a   Villarreal, Lucia ^a   Garcia, Hector H ^b   Verastegui, Manuela R ^b   Gilman, Robert H ^c  

^a UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITAZOXANIDE; OXFENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ECHINOCOCCOSIS; LIVER CYST; LUNG CYST; NONHUMAN; SHEEP;

ECHINOCOCCUS GRANULOSUS; OVIS ARIES;

EID: 62949182186     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.367     Document Type: Article

References (41)

1. Eckert J, Deplazes P, 2004. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 17: 107-135.
2. Eckert J, Conraths FJ Tackmann K, 2000. Echinococcosis: an emerging or re-emerging zoonosis? Int J Parasitol 30:1283-1294.
3. SchantzPM, 1991.Parasitic zoonoses in perspective. Int J Parasitol 21:161-170.
4. Dueger EL, Moro PL, Gilman RH, 1999. Oxfendazole treatment of sheep with naturally acquired hydatid disease. Antimicrob Agents Chemother 43:2263-2267.
5. Morris DL, Clarkson MJ, Stallbaumer MF, Pritchard J, Jones RS, Chinnery JB, 1985. Albendazole treatment of pulmonary hydatid cysts in naturally infected sheep: a study with relevance to the treatment of hydatid cysts in man. Thorax 40:453-458.
6. Pawlowski ZS, Eckert J, Vuitton DA, Ammann R, Kern P, Craig PS, Dar FK, De Rosa F, Filice C, Gottstein B, Grimm F, Macpherson CN, Sato N, Todorov T, Uchino J, von Sinner W, Wen H, 2001. Echinococcosis in humans: clinical aspects, diagnosis and treatment. Gemmell JE, Mal JR, Roberts MG, Meslin F, Pawlowski Z, eds. WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. Paris: World Health Organization, 20-66.
7. Thompson R, McManus DP, 2001. Aetiology: parasites and life-cycles. Eckert J, Gemmell MA, Meslin F, Pawlowski Z, eds WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. Paris: World Health Organization, 1-19.
8. Pawlowski Z, Eckert J, Vuitton DA, Ammann R, Kern P, Craig PS, Diaz KF, De Rosa F, Filice C, Gottstein B, Grimm F, Macpherson CN, Sato N, Todorov T, Uchino J, von Sinner W, Wen H, 2002. Echinococcosis in humans: clinical aspects, diagnosis and treatment. Eckert J, Gemmell MA, Meslin F, Pawlowski Z, eds. WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern. Paris: World Health Organization, 20-71.
9. Mohamed AE, Yasawy MI, Al Karawi MA, 1998. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology 45: 1690-1694.
10. Horton RJ, 1997. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop 64:79-93.
11. Horton RJ, 1989. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 83: 97-102.
12. Marriner SE, Bogan JA, 1981. Pharmacokinetics of oxfendazole in sheep. Am J Vet Res 42:1143-1145.
13. Gonzalez AE, Falcon N, Gavidia C, Garcia HH,Tsang VC, Bernal T, Romero M, Gilman RH, 1997. Treatment of porcine cysticer- cosis with oxfendazole: a dose-response trial. Vet Rec 141: 420-422.
14. Blanton RE, Wachira TM, Zeyhle EE, Njoroge EM,Magambo JK, Schantz PM, 1998. Oxfendazole treatment for cystic hydatid disease in naturally infected animals. Antimicrob Agents Chemother 42:601-605.
15. Stettler M, Fink R, Walker M, Gottstein B, Geary TG, Rossignol JF, Hemphill A, 2003. In vitro parasiticidal effect of nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother 47:461-414.
16. Walker M, Rossignol JF, Torgerson P, Hemphill A, 2004. In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother 54:609-616.
17. Moro PL, McDonald J, Gilman RH, Silva B, Verastegui M, Malqui V, Lescano G, Falcon N, Montes G, Bazalar H, 1997. Epidemiology of Echinococcus granulosus infection in the central Peruvian Andes. Bull World Health Organ 75:553-561.
18. Stockis A, De Bruyn S, Gengler C, Rosillon D, 2002. Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. Int J Clin Pharmacol Ther 40:221-227.
19. Davila-Gutierrez CE,Vasquez C, Trujillo-Hernandez B, Huerta M, 2002. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg 66:251-254.
20. Rossignol JF, Abaza H, Friedman H, 1998. Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 92:103-104.
21. Soraci AL, Mestorino N, Errecalde JO, 1997. Some pharmacokinetic parameters of oxfendazole in sheep. Vet Res Commun 21:283-287.
22. Parashar A, Arya R, 2005. Nitazoxanide. Indian Pediatr 42:1161-1165.
23. Dueger EL, Gilman RH, 2001. Prevalence, intensity, and fertility of ovine cystic echinococcosis in the central Peruvian Andes. Trans R Soc Trop Med Hyg 95:379-383.
24. Himonas C, Antoniadou-Sotiriadou K, Papadopoulos E, 1994. Hydatidosis of food animals in Greece: prevalence of cysts containing viable protoscoleces. J Helminthol 68:311-313.
25. Theodos CM, Griffiths JK, D'Onfro J, Fairfield A, Tzipori S, 1998. Efficacy of nitazoxanide against Cryptosporidium parvurn in cell culture and in animal models. Antimicrob Agents Chemother 42:1959-1965.
26. Craig PS, Larrieu E, 2006. Control of cystic echinococcosis/hydati-dosis: 1863-2002. Adv Parasitol 61: 443-508.
27. Heath D, Yang W, Li T, Xiao Y, Chen X, Huang Y, Yang Y, Wang Q, Qiu J, 2006. Control of hydatidosis. Parasitol Int 55 (Suppl): S247-S252.
28. Lightowlers MW, Lawrence SB, Gauci CG, Young J, Ralston MJ, Maas D. Health DD, 1996. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 18: 457-462.
29. Lanusse CE. Gascon LH, Prichard RK, 1995. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep. J Vet Pharmacol Ther 18: 196-203.
30. Todorov T, Vutova K, Donev S, Ivanov A, Katzarov K, Takov D, 2005. The types and timing of the degenerative changes seen in the cysts during and after benzimidazole treatment of cystic echinococcosis. Ann Trop Med Parasitol 99: 649-659.
31. Urrea-Paris MA, Moreno MJ, Casado N, Rodriguez-Caabeiro F, 2002. Relationship between the efficacy of praziquantel treatment and the cystic differentiation in vivo of Echinococcus granulosus metacestode. Parasitol Res 88: 26-31.
32. Teggi A, Lastilla MG, De Rosa F, 1993. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 37:1679-1684.
33. Menezes da Silva A, 2003. Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop 85: 237-242.
34. Zhang W, Li J, McManus DP, 2003. Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 16: 18-36.
35. Kern P, 2003. Echinococcus granulosus infection: clinical presentation, medical treatment and outcome. Langenbecks Arch Surg 388:413-420.
36. Reinemeyer CR, Courtney CH, 2003. Fármacos contra cestodos y trematodos. Adams HR, ed. Farmacología y Terapéutica Veterinaria. Zaragosa, Spain: Editorial Acribia, 1049-1061.
37. Hemphill A, Mueller J. Esposito M, 2006. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7: 953-964.
38. García JL, Álvarez AI, Redondo PA, Prieto JG, 1997. Estudio de la fertilidad y viabilidad de quistes hidatídicos ovinos. Rev Esp Salud Publico 71:445-449.
39. Moro PL, Bonifacio N, Gilman RH, Lopera L, Silva B,Takumoto R, Verastegui M, Cabrera L, 1999. Field diagnosis of Echinococcus granulosus infection among intermediate and definitive hosts in an endemic focus of human cystic echinococcosis. Trans R Soc Trop Med Hyg 93: 611-615.
40. Purriel P, Schantz PM, Beovide H, Mendoza G, 1973. Human echinococcosis (hydatidosis) in Uruguay: a comparison of indices of morbidity and mortality, 1962-71. Bull World Health Organ 49: 395-402.
41. Morris DL, Richards KS, Clarkson MJ, Taylor DH, 1990. Comparison of albendazole and praziquantel therapy of Echinococcus granulosus in naturally infected sheep. Vet Parasitol 36:83-90.